Skip to main content

Bank of New York Mellon Corp

Bank

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1390777 NEW YORK, NY

Position in LGND

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$41,429,278
+$17,590,475 QoQ
Shares Held
131,068
+9.8% QoQ
Ownership
0.657%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 5%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. LGND ranks #29 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,429,278 131,068
2026-03-31 $23,838,803 119,403
2025-12-31 $23,116,638 122,265
2025-09-30 $22,585,170 127,499
2025-06-30 $14,563,086 128,106
2025-03-31 $13,307,671 126,571
2024-12-31 $13,928,640 129,992
2024-09-30 $13,496,032 134,839
2024-06-30 $12,301,115 145,990
2024-03-31 $10,757,685 147,164
2023-12-31 $11,110,019 155,559
2023-09-30 $8,731,958 145,727
2023-06-30 $10,949,754 151,869
2023-03-31 $11,116,457 151,121
2022-12-31 $10,476,441 156,833
2022-09-30 $13,996,740 162,545
2022-06-30 $14,691,130 164,662
2022-03-31 $20,705,812 184,068
2021-12-31 $29,604,561 191,665
2021-09-30 $26,277,687 188,614
2021-06-30 $24,922,947 189,976
2021-03-31 $27,529,405 180,580
2020-12-31 $19,601,979 197,104
2020-09-30 $19,888,605 208,651
2020-06-30 $24,882,586 222,464
2020-03-31 $17,001,190 233,790